Whitehawk Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $7,145 | $7,239 |
Gross Profit | -5 | -16 | 6,385 | -7,898 |
EBITDA | -17,741 | -52,599 | -15,169 | -18,226 |
EBIT | -17,746 | -52,615 | -15,218 | -18,273 |
Net Income | -17,746 | -52,615 | 73,016 | -18,273 |
Net Change In Cash | 0 | 0 | 7,145 | 7,239 |
Free Cash Flow | -15,378 | -52,958 | -12,415 | -15,239 |
Cash | 37,931 | 144,936 | 227,569 | 28,670 |
Basic Shares | 69,204 | 69,083 | 27,087 | 27,087 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $25,983 | $24,354 | $15,216 | $1,120 |
Gross Profit | -28,071 | -27,384 | -18,781 | -18,550 |
EBITDA | -64,627 | -71,764 | -58,798 | -36,956 |
EBIT | -64,820 | -71,933 | -58,957 | -37,061 |
Net Income | -63,691 | -65,765 | -60,513 | -110,090 |
Net Change In Cash | 25,983 | 24,354 | 15,216 | 1,120 |
Free Cash Flow | -61,204 | -63,635 | -50,084 | -22,469 |
Cash | 28,670 | 62,888 | 39,019 | 148,989 |
Basic Shares | 27,030 | 26,918 | 22,511 | 8,923 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | -$0.26 |
2025-06-30 | -$0.76 |
